A STUDY TO DETERMINE THE EFFICACY AND SAFETY OF LENALIDOMIDE IN PATIENTS WITH MANTLE CELL NHL WHO HAVE RELAPSED OR PROGRESSED AFTER TREATMENT WITH BORTEZOMIB OR ARE REFRACTORY TO BORTEZOMIB. THE "EMERGE" TRIAL: